NPO Petrovax Pharm received a Russian Nanotechnology Product label, confirming Grippol Plus flu vaccine’s quality, effectiveness and safety. The label is given to companies that manufacture products with the use of Russian nanotechnology and that meet high quality, safety and environmental requirements.
The award ceremony took place in Moscow at the IVth Congress of Nanotechnology Companies. Anatoly Chubais, Chairman of the Board of Rusnano Managing Company and Aleksey Abramov, the Head of Rosstandart handed the label Award Diploma to Elena Arkhangelskaya, NPO Petrovax Pharm President.
Grippol Plus is the first and only medical product awarded the label. The vaccine has been used successfully under the National Vaccination Schedule for children 6 months and older and for pregnant women. More than 100 million people have already been vaccinated.